(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇
概要:(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇(CAS 110352-77-7)是一种化学化合物,分子式为C48H78O17,分子量为926.52 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务,支持克级到吨级规格。
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-4,5-dihydroxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
又称:Saikosaponin BK1, J2.767.656A, (2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-4,5-dihydroxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol, (2S,3R,4R,5R,6S)-2-((2R,3S,4R,5R,6R)-6-(((3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl)oxy)-4,5-dihydroxy-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxymethyl)oxan-3-yl)oxy-6-methyloxane-3,4,5-triol, (2S,3R,4R,5R,6S)-2-((2R,3S,4R,5R,6R)-6-(((3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl)oxy)-4,5-dihydroxy-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)oxymethyl)tetrahydropyran-3-yl)oxy-6-methyl-tetrahydropyran-3,4,5-triol
| 分子式 | C48H78O17 |
|---|---|
| 分子量 | 926.52 g/mol |
| LogP | 1.6 |
| 拓扑极性表面积 | 278.0 Ų |
| 氢键供体数 | 11 |
| 氢键受体数 | 17 |
| 可旋转键数 | 9 |
| 精确质量 | 926.5239 |
| 重原子数 | 65 |
| 复杂度 | 1790.0 |
化学标识符
| CAS 编号 | 110352-77-7 |
|---|---|
| SMILES | C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O[C@H]3CC[C@]4([C@H](C3(C)C)CC[C@@]5([C@@H]4C=CC6=C7CC(CC[C@@]7([C@@H](C[C@]65C)O)CO)(C)C)C)C)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O |
| InChIKey | PYJMYPPFWASOJX-YSNVVKQWSA-N |
📋 应用领域
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇主要应用于有机合成与工艺化学。在实验室中常作为通用有机合成砌块使用。科弘生物供应(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇(CAS 110352-77-7),提供毫克级到公斤级定制合成,随货提供COA、MSDS及HPLC/NMR/MS分析报告。
产品概述
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇(CAS 110352-77-7)是一种精细化学品,分子式为C48H78O17,分子量 926.52 g/mol。 该化合物又名Saikosaponin BK1、J2.767.656A。
科弘生物提供目录供应与定制合成(毫克至吨级),支持HPLC/NMR/MS全套检测,随货附COA与MSDS。请告知所需数量与纯度,获取报价与货期。
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇化学性质概览
属性洞察:(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的XLogP值为1.6,表明具有中等亲脂性,在水溶性和膜透过性之间取得平衡。 TPSA为278.0 Ų,极性较高,提示该化合物膜透过性可能受限但水溶性较好。 根据Lipinski五规则,(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇有11个氢键供体和17个氢键受体,可能需要考虑配方优化。
常见问题
常见问题
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的CAS号是多少?
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的CAS号为110352-77-7。
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的分子式是什么?
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的分子式为C48H78O17。
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的分子量是多少?
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的分子量为926.52 g/mol。
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇有哪些应用?
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇主要应用于有机合成与工艺化学。在实验室中常作为通用有机合成砌块使用。科弘生物供应(2S,3R,4R,5R,6...
在哪里可以购买(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇?
您可以直接向科弘生物询价(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇的定制合成服务?
是的,科弘生物提供(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-6-[[(3S,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-羟基-8a-(羟基甲基)-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4a,5,6,7,8,9,10,12,14a-十二氢苝-3-基]氧代]-4,5-二羟基-2-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代甲基]噁烷-3-基]氧代-6-甲基氧杂环己烷-3,4,5-三醇及相关化合物的定制合成服务。请联系我们并告知您的具体需求,包括数量、纯度和交期。